NIAID Banner Logo Image

HIV Citations List: February, 2018

Literature Citations

1. Anti-HIV Activity of Alkaloids from Dasymaschalon echinatum. Bunteang, S., W. Chanakul, S. Hongthong, C. Kuhakarn, W. Chintakovid, N. Sungchawek, R. Akkarawongsapat, J. Limthongkul, N. Nantasaen, V. Reutrakul, and T. Jaipetch. Natural Product Communications, 2018. 13(1): p. 29-32. ISI[000423651000009].
[WOS]. HIV_02_2018.


2. Polycyclic Polyprenylated Acylphloroglucinols and Biphenyl Derivatives from the Roots of Garcinia nuntasaenii Ngerns. & Suddee. Chaturonrutsamee, S., C. Kuhakarn, P. Surawatanawong, S. Prabpai, P. Kongsaeree, T. Jaipetch, P. Piyachaturawat, S. Jariyawat, R. Akkarawongsapat, K. Suksen, J. Limthongkul, C. Napaswad, N. Nuntasaen, and V. Reutrakul. Phytochemistry, 2018. 146: p. 63-74. PMID[29247893].
[PubMed]. HIV_02_2018.


3. Ahmpatinin iBu, a New HIV-1 Protease Inhibitor, from Streptomyces sp CPCC 202950. Chen, M.H., S.S. Chang, B. Dong, L.Y. Yu, Y.X. Wu, R.Z. Wang, W. Jiang, Z.P. Gao, and S.Y. Si. RSC Advances, 2018. 8(10): p. 5138-5144. ISI[000424024200010].
[WOS]. HIV_02_2018.


4. Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. Cohen, Y.Z., J.C.C. Lorenzi, M.S. Seaman, L. Nogueira, T. Schoofs, L. Krassnig, A. Butler, K. Millard, T. Fitzsimons, X. Daniell, J.P. Dizon, I. Shimeliovich, D.C. Montefiori, M. Caskey, and M.C. Nussenzweig. Journal of Virology, 2018. 92(5):p. e01883-01817. PMID[29237833].PMCID[PMC5809738].
[PubMed]. HIV_02_2018.


5. Trametinib Suppresses HIV-1 Replication by Interfering with the Disassembly of Human Immunodeficiency Virus Type 1 Capsid Core. Dochi, T., A. Akita, N. Kishimoto, N. Takamune, and S. Misumi. Biochemical and Biophysical Research Communications, 2018. 495(2): p. 1846-1850. PMID[29197575].
[PubMed]. HIV_02_2018.


6. Multi-target Inhibition by Four Tandem shRNAs Embedded in Homo- or Hetero-miRNA Backbones. Du, X., Y.H. Cai, W.J. Xi, R. Zhang, L.T. Jia, A.G. Yang, J. Zhao, and B. Yan. Molecular Medicine Reports, 2018. 17(1): p. 307-314. ISI[000423433300038].
[WOS]. HIV_02_2018.


7. Generation of a Dual-target, Safe, Inexpensive Microbicide That Protects against HIV-1 and HSV-2 Disease. Farr Zuend, C., J.F. Nomellini, J. Smit, and M.S. Horwitz. Scientific Reports, 2018. 8(2786): 15pp. PMID[29434285]. PMCID[PMC5809452].
[PubMed]. HIV_02_2018.


8. Identification of Novel 2-Benzoxazolinone Derivatives with Specific Inhibitory Activity against the HIV-1 Nucleocapsid Protein. Gamba, E., M. Mori, L. Kovalenko, A. Giannini, A. Sosic, F. Saladini, D. Fabris, Y. Mely, B. Gatto, and M. Botta. European Journal of Medicinal Chemistry, 2018. 145: p. 154-164. PMID[29324338].
[PubMed]. HIV_02_2018.


9. BI-2536 and BI-6727, Dual Polo-like Kinase/bromodomain Inhibitors, Effectively Reactivate Latent HIV-1. Gohda, J., K. Suzuki, K. Liu, X. Xie, H. Takeuchi, J.I. Inoue, Y. Kawaguchi, and T. Ishida. Scientific Reports, 2018. 8(3521): 13pp. PMID[29476067]. PMCID[PMC5824842].
[PubMed]. HIV_02_2018.


10. Discovery of Biphenyl-substituted Diarylpyrimidines as Non-Nucleoside Reverse Transcriptase Inhibitors with High Potency against Wild-type and Mutant HIV-1. Jin, K., H. Yin, E. De Clercq, C. Pannecouque, G. Meng, and F. Chen. European Journal of Medicinal Chemistry, 2018. 145: p. 726-734. PMID[29353724].
[PubMed]. HIV_02_2018.


11. Anti-HIV 1 Activity of Xanthones from the Bark of Mammea harmandii.Liangsakul, P., C. Kuhakarn, S. Hongthong, S. Jariyawat, K. Suksen, R. Akkarawongsapat, J. Limthongkul, C. Napaswad, and V. Reutrakul. Natural Product Communications, 2018. 13(1): p. 53-56. ISI[000423651000015].
[WOS]. HIV_02_2018.


12. C-21 Steroid Derivatives from the Dai Herbal Medicine Dai-Bai-Jie, the Dried Roots of Marsdenia tenacissima, and their Screening for anti-HIV Activity. Pang, X., L.P. Kang, X.M. Fang, H.S. Yu, L.F. Han, Y. Zhao, L.X. Zhang, L.Y. Yu, and B.P. Ma. Journal of Natural Medicines, 2018. 72(1): p. 166-180. PMID[28914410].
[PubMed]. HIV_02_2018.


13. Synthesis of 3 '-Azido-D/L-nucleosides. Ren, H., J.C. Tao, and H.Y. An. Chinese Journal of Organic Chemistry, 2018. 38(1): p. 138-147. ISI[000424748800015].
[WOS]. HIV_02_2018.


14. Rational CCL5 Mutagenesis Integration in a Lactobacilli Platform Generates Extremely Potent HIV-1 Blockers. Secchi, M., V. Grampa, and L. Vangelista. Scientific Reports, 2018. 8(1890): 13pp. PMID[29382912]. PMCID[PMC5790001].
[PubMed]. HIV_02_2018.


15. Antivirals Acting on Viral Envelopes via Biophysical Mechanisms of Action. Speerstra, S., A.A. Chistov, G.V. Proskurin, A.V. Aralov, E.A. Ulashchik, P.P. Streshnev, V.V. Shmanai, V.A. Korshun, and L.M. Schang. Antiviral Research, 2018. 149: p. 164-173. PMID[29191427].
[PubMed]. HIV_02_2018.


16. Mannose Receptor 1 Restricts HIV Particle Release from Infected Macrophages.Sukegawa, S., E. Miyagi, F. Bouamr, H. Farkasova, and K. Strebel. Cell Reports, 2018. 22(3): p. 786-795. PMID[29346774]. PMCID[PMC5792083].
[PubMed]. HIV_02_2018.


17. Synthesis of Pentacyclic Iminosugars with Constrained Butterfly-like Conformation and Their HIV-RT Inhibitory Activity. Yan, L.H., Z.Q. Yin, L.P. Niu, J. Shao, H. Chen, and X.L. Li. Bioorganic & Medicinal Chemistry Letters, 2018. 28(3): p. 425-428. PMID[29269212].
[PubMed]. HIV_02_2018.


18. Quercetin Synergistically Reactivates Human Immunodeficiency Virus Type 1 Latency by Activating Nuclear Factorkappa-B. Yang, X., X. Zhu, H. Ji, J. Deng, P. Lu, Z. Jiang, X. Li, Y. Wang, C. Wang, J. Zhao, Y. Wang, Y. Zhong, H. Yang, and H. Zhu. Molecular Medicine Reports, 2018. 17(2): p. 2501-2508. PMID[29207194].
[PubMed]. HIV_02_2018.


19. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression. Zaikos, T.D., M.M. Painter, N.T. Sebastian Kettinger, V.H. Terry, and K.L. Collins. Journal of Virology, 2018. 92(6): p. e02110-02117. PMID[29298886].
[PubMed]. HIV_02_2018.


20. SJP-L-5 Inhibits HIV-1 Polypurine Tract Primed Plus-strand DNA Elongation, Indicating Viral DNA Synthesis Initiation at Multiple Sites under Drug Pressure. Zhang, X.J., R.R. Wang, H. Chen, R.H. Luo, L.M. Yang, J.P. Liu, H.D. Sun, H.B. Zhang, W.L. Xiao, and Y.T. Zheng. Scientific Reports, 2018. 8(2574): 11pp. PMID[29416083].PMCID[PMC5803243].
[PubMed]. HIV_02_2018.


21. Receptor-targeted Aptamer-siRNA Conjugate-directed Transcriptional Regulation of HIV-1. Zhou, J.H., D. Lazar, H.T. Li, X. Xia, S. Satheesan, P. Charlins, D. O'Mealy, R. Akkina, S. Saayman, M.S. Weinberg, J.J. Rossi, and K.V. Morris. Theranostics, 2018. 8(6): p. 1575-1590. ISI[000424662800009].
[WOS]. HIV_02_2018.


22. GalNAc-specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors. Zhou, R., X. Wang, H. Liu, L. Guo, Q. Su, H. Wang, T. Vasiliadis, W. Ho, and J. Li. Journal of Virology, 2018. 92(6): p. e01720-01717. PMID[29263266].
[PubMed]. HIV_02_2018.


23. Discovery of Novel Diarylpyrimidines as Potent HIV-1 NNRTIs by Investigating the Chemical Space of a Less Explored "Hydrophobic Channel". Zhou, Z.X., T. Liu, D.W. Kang, Z.P. Huo, G.C. Wu, D. Daelemans, C.E. De, C. Pannecouque, P. Zhan, and X.Y. Liu. Organic & Biomolecular Chemistry, 2018. 16(6): p. 1014-1028. PMID[29349445].
[PubMed]. HIV_02_2018.

Patent Citations

24. Preparation of C-3 Novel Triterpenone with C-17 N-Amide Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, and B.R. Kasireddy. Patent. 2018. 2017-IB54858 2018029610: 56pp.
[Patent]. HIV_02_2018.


25. Preparation of C-3 Novel Triterpenones with C-28 Heterocycle Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, and B.R. Kasireddy. Patent. 2018. 2017-IB54840 2018029602: 70pp.
[Patent]. HIV_02_2018.


26. Preparation of C-3 Novel Triterpenone with C-17 Reverse Amide Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, B.R. Kasireddy, C. Thomas Wild, D. Eugene Martin, and T. John Nitz. Patent. 2018. 2017-IB54843 2018029604: 101pp.
[Patent]. HIV_02_2018.


27. Preparation of Novel Triterpenone with C-3,C-28 Diamide Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, B.R. Kasireddy, C. Thomas Wild, D. Eugene Martin, and T. John Nitz. Patent. 2018. 2017-IB54807 2018025247: 49pp.
[Patent]. HIV_02_2018.


28. Preparation of Cyclopropacyclopentapyrazolylacetamide Compounds Useful for the Prophylactic or Therapeutic Treatment of HIV Virus Infection. Graupe, M., S.J. Henry, J.O. Link, C.W. Rowe, R.D. Saito, S.D. Schroeder, D. Stefanidis, W.C. Tse, and J.R. Zhang. Patent. 2018. 2017-US47416 2018035359: 139pp.
[Patent]. HIV_02_2018.

Database last updated: September 2018